Fast Company - - Most Creative Companies -

MILE­STONES San Fran­cisco–based Ge­nen­tech re­ceived FDA ap­proval this spring for an MS drug called Ocre­vus, the first med­i­ca­tion for the most se­vere form of the dis­ease. The drug went on the mar­ket in April. CHAL­LENGES Though the FDA ap­proved Ge­nen­tech’s blad­der can­cer treat­ment last year, the drug re­cently failed a late-stage trial, which could cause the FDA to over­turn its rul­ing. BUZZ

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.